Vertex, Seattle Genetics, Alpine withdraw from investor conference as biotechs brace for coronavirus
In the first glimpse of how the coronavirus’s growing US spread could disrupt operations at American biotechs, a pair of major companies withdrew today from a large investor conference.
Vertex Pharmaceuticals, Seattle Genetics and Alpine Immune were each scheduled to present Tuesday at the Cowen Healthcare Conference in Boston. All announced on Monday, the first day of the conference, they were canceling their appearances, citing the growing spread of the virus, officially known as SARS-CoV-2.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 76,900+ biopharma pros reading Endpoints daily — and it's free.